Clinical Trial Update: Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Renagel (sevelamer) to calcium acetate for safety and efficacy in patients on peritoneal dialysis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Calcium Acetate (Calcium Acetate)
• Renagel (sevelamer)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Peritoneal Dialysis, Chronic Kidney Disease | Phase 3 | Status: COMPLETED